Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
Demo Company

CT Texture Tumor Analysis May Become Useful Biomarker for Localized Esophageal Cancer

By Medimaging International staff writers
Posted on 20 Feb 2013
Computed tomography (CT) texture analysis of primary tumors may become a helpful imaging biomarker in localized esophageal cancer after administering neoadjuvant chemotherapy, according to recent research.

The study’s findings were presented February 9, 2013, at the 2013 Cancer Imaging and Radiation Therapy Symposium, held in Orlando (FL, USA). This symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North American (RSNA).

This study assessed the tumoral texture analysis on baseline and post-treatment CT scans of 31 patients with localized resectable esophageal cancer, with a median age of 63, and who received neoadjuvant chemotherapy between 2007 and 2010. CT scans were performed before and after the use of chemotherapy and before surgery. All patients received fluorouracil-based and platinum chemotherapy followed by surgery. Texture parameters (mean-gray level intensity [MGI], entropy, uniformity, skewness, kurtosis, and standard deviation of histogram [SDH]) were derived for four filter values to highlight structures of different spatial width: 1.0 (fine texture), 1.5–2.0 (medium), and 2.5 (coarse). Median follow-up was 21.9 months. Primary tumors became more homogenous following chemotherapy because entropy decreased and uniformity increased. Smaller change in skewness following chemotherapy was a key prognostic factor—median overall survival was 36.1 months vs. 11.1 months. Lower baseline entropy and lower post-treatment MGI were also tied with increased survival, although they demonstrated only a trend toward significance.

Texture analysis of the CT scans is a post-processing step, which was performed using exclusive software (TexRAD) that enriches the images in ultrafine clarity not visible to the human eye. Specific tumoral characteristics changed consistently following chemotherapy, and some features were linked with overall survival.

“Though these results are for a very small number of patients, they suggest that the tumoral texture features may provide valuable information that could help us to distinguish which patients will do well following chemotherapy and which ones will do poorly,” concluded Connie Yip, MD, the lead study author, a clinical research fellow at King’s College London (UK), and an associate consultant in radiation oncology at the National Cancer Center, Singapore. “As a biomarker for treatment efficacy, this technique could save patients from unnecessary surgery and provide more definitive guidance in developing patient treatment plans with improved outcomes.”

Related Links:

King’s College London




Channels

MRI

view channel
Image: Siemens Healthcare MAGNETOM Avanto 1.5-T MRI Scanner (Photo courtesy of Siemens Healthcare).

MRI Technique Allows for “Fingerprinting” of Tissues and Diseases for Faster Diagnoses

New findings published in the journal Nature indicate that a new Magnetic Resonance Imaging (MRI) technique, called Magnetic Resonance Fingerprinting (MRF), could provide much more information with each... Read more

Ultrasound

view channel

New Ultrasound System Enhances Patient Care and User Experience

A new ultrasound system with innovative specialized transducers and improved image quality, intended for general imaging, women’s health, and shared service applications, has been announced. The system features improved accuracy, performance, assessment tools, advanced automation, and an enhanced user experience.... Read more

Nuclear medicine

view channel

Clinical Study Shows Added Value of Amyloid PET Imaging in the Diagnosis and Treatment of Dementia

Early-onset dementia patients could benefit from a new PET imaging agent developed by a major medical imaging vendor. The results of a clinical study showing the effectiveness of the amyloid PET imaging agent were presented at the Alzheimer’s Association International Conference (AAIC 2015) in Washington DC (USA).... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Imaging IT

view channel
Image: Siemens Healthcare’s syngo.via MM Oncology facilitates compliance by clinicians to British Thoracic Society guidelines for the investigation and management of pulmonary nodules.(Photo courtesy of Siemens Healthcare).

Oncology Software Update Compliant with New BTS Guidelines

A key diagnostic imaging vendor has announced that it has modified its oncology software solution to ensure compliance with new British Thoracic Society (BTS) guidelines for lung nodule screening.... Read more

Industry News

view channel

Report Forecasts Growth of Global Computed Tomography Sector to USD 6 billion by 2019

A new report has been published that analyzes global Computed Tomography (CT) market shares, strategies, and forecasts, for the years 2013 to 2018. The report entitled “Global Computed Tomography (CT) Market Shares, Strategies, and Forecasts, 2013 to 2018,” predicts that global CT markets will continue to grow moderately... Read more
 

Events

11 Sep 2015 - 12 Sep 2015
19 Sep 2015 - 24 Sep 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.